Antileukotrienes in upper airway inflammatory diseases - Wikidata - awgldk - TriplyDB

Antileukotrienes in upper airway inflammatory diseases

Antileukotrienes in upper airway inflammatory diseases

http://www.wikidata.org/entity/Q28267571

about

A Review of Classification Schemes for Chronic Rhinosinusitis with Nasal Polyposis Endotypes Chronic rhinosinusitis: the rationale for current treatments.Montelukast, current indications and prospective future applications.Subclinical lower airways correlates of chronic allergic and non-allergic rhinitis.Biliverdin Reductase inhibitors did not improve severe unconjugated hyperbilirubinemia in vivo.Inhibition of 5-lipoxygenase inhibitor zileuton in high-fat diet-induced nonalcoholic fatty liver disease progression model.Inhibition of 5-lipoxygenase alleviates graft-versus-host disease.Relationship Between Gender and the Effectiveness of Montelukast: An Italian/Danish Register-Based Retrospective Cohort Study

P2860

Q28079332-0EC0BB8A-4FC4-438E-854D-83530BA90708 Q38833522-A1FA91B3-7265-4528-AC1F-8457EE1C2ED5 Q38835130-5887A6BB-2ABD-43FA-BF2B-DE35866B2CCD Q39250085-2EAB29A3-5305-4933-ABB3-075BA8F006E2 Q42266741-6C72AF3C-4046-47AB-9B39-95D8DE33B4A2 Q47099295-F5721C3B-E350-45FD-8D30-3AC58F8C7B6F Q47744316-7A47D20A-3EFE-4A28-9C06-FCB93CB51F53 Q58803402-DDDD000E-E022-447A-8A23-4E2035B050BF

P2860

Antileukotrienes in upper airway inflammatory diseases

http://www.wikidata.org/entity/Q28267571

description

2015 nî lūn-bûn

@nan

2015 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Antileukotrienes in upper airway inflammatory diseases

@ast

Antileukotrienes in upper airway inflammatory diseases

@en

Antileukotrienes in upper airway inflammatory diseases

@nl

type

label

Antileukotrienes in upper airway inflammatory diseases

@ast

Antileukotrienes in upper airway inflammatory diseases

@en

Antileukotrienes in upper airway inflammatory diseases

@nl

prefLabel

Antileukotrienes in upper airway inflammatory diseases

@ast

Antileukotrienes in upper airway inflammatory diseases

@en

Antileukotrienes in upper airway inflammatory diseases

@nl

P1433

Q28267571-031EA0BB-811B-4F7E-851C-AB0B867D0976

P1476

Q28267571-5AA71A00-C20A-41C4-B924-22A0BBBBA913

P2093

Q28267571-332F6FCC-9700-4142-B058-E17D7A857AD9

Q28267571-5F1F7AF1-98C5-44B4-B494-F60E013EEC1F

P2860

Q28267571-0117ABA8-E110-408C-9983-1BA863C160FE

Q28267571-0148E369-98F6-4853-B1F3-787193D2DA03

Q28267571-061A2BF7-4FB8-4D5A-B491-B806F144207E

Q28267571-0DF5B99D-5193-422C-95ED-4C4CFB40D7D6

Q28267571-13B2E841-C7BE-48BA-9DD0-E3E6069DC0FE

Q28267571-13D45766-91FD-4F05-BD82-5E30AE223CBC

Q28267571-1A54B65C-BE11-468A-B3E6-DB028FB99204

Q28267571-212AE0A1-3211-4787-AFE9-1F4A3A2B1F45

Q28267571-21A362D0-872D-4F72-99FB-250B9F524158

Q28267571-25288580-29DA-4A5A-AE92-B3201E8D1A5C

P2888

Q28267571-0F974833-0108-403F-8318-0010B33E3F03

P304

Q28267571-5993483A-A9B0-491B-993E-76B981866A6C

P31

Q28267571-6B924CCF-0450-4A03-8A8D-ADDFC45E3BF7

P3181

Q28267571-F94F4E44-6D18-45E5-8AC8-F284A2EE80A5

P356

Q28267571-13D83B06-3DFB-401A-8DDA-5A712AAAFABC

P407

Q28267571-DED96CE0-609B-4971-A723-EE6D93840D19

P433

Q28267571-EF7CA7C4-8C5F-4AF9-B6C2-52E194443B00

P478

Q28267571-FF05C103-86A5-4E1B-8267-3CD64EA10A0D

P50

Q28267571-2BF94BCF-F4D3-4A5A-92BE-054317F9E882

Q28267571-3A4FA5E4-D409-4B2D-BB1E-94D658131B39

P577

Q28267571-492D5763-2478-45BA-897D-32FF6029BDE1

P5875

Q28267571-8D3BEDB4-F3E8-4F0C-ABE6-965B2FC9000E

P6179

Q28267571-DFD8E027-25B8-4566-B8C1-6010EFD58719

P698

Q28267571-075D9CF5-F42B-4464-A611-7E6D90E422E6

P3181

P356

S11882-015-0564-7

P1433

Current Allergy and Asthma Reports

P1476

Antileukotrienes in upper airway inflammatory diseases

@en

P2093

Ethem Şahin

http://www.w3.org/2001/XMLSchema#string

Kagan Ipci

http://www.w3.org/2001/XMLSchema#string

P2860

Overexpression of leukotriene C4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma

Functional recognition of a distinct receptor preferential for leukotriene E4 in mice lacking the cysteinyl leukotriene 1 and 2 receptors

Leukotriene E4-induced pulmonary inflammation is mediated by the P2Y12 receptor

Leukotriene antagonists in nasal polyposis: a meta-analysis and systematic review.

Stepping down from inhaled corticosteroids with leukotriene inhibitors in asthma: a systematic review and meta-analysis

Prostaglandin, leukotriene, and lipoxin balance in chronic rhinosinusitis with and without nasal polyposis

An open audit of montelukast, a leukotriene receptor antagonist, in nasal polyposis associated with asthma

Treatment of ASS-Associated Polyposis (ASSAP) with a cysteinyl leukotriene receptor antagonist - a prospective drug study on its antiinflammatory effects

Leukotriene-receptor expression on nasal mucosal inflammatory cells in aspirin-sensitive rhinosinusitis

Expression of 5-lipoxygenase and cyclooxygenase pathway enzymes in nasal polyps of patients with aspirin-intolerant asthma

P2888

s11882-015-0564-7

P304

64

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3584788

http://www.w3.org/2001/XMLSchema#string

P356

10.1007/S11882-015-0564-7

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P50

Nuray Bayar Muluk

P577

2015-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

282044885

http://www.w3.org/2001/XMLSchema#string

P6179

1021611782

http://www.w3.org/2001/XMLSchema#string

P698

26385352

http://www.w3.org/2001/XMLSchema#string